Announcements
Projects
Orgs
Project
Articles 40
Votes 0
OncLive

Authors 41

OncLive Staff
Ryan Scott
Ashling Wahner
Gina Mauro
Silas Inman
Kristi Rosa
Wayne Kuznar
Jason Harris
Josep Tabernero
MD
PhD
Rohit Kumar
Ryan Fecteau
Prateek Gulhati
Megan Kruse
Caroline Seymour
Marisol Miranda-Galvis
DDS
MS
Inderjit Mehmi
Johannes Schetelig
MSc
Joachim G. J. V. Aerts
Toufic A. Kachaamy
Madappa Kundranda
Tamas A. Gonda
Lynn G. Feun
Joshua Hurwitz
Phillip Dennis
Vice President
Lung Cancer
CEACAM Global Project Head
Sanofi
Hemant S. Murthy
University of Miami Health System
Brian Ramnaraign
Komal Jhaveri
FACP
Brett L. Ecker
Kevin Kalinsky
Courtney Flaherty
Biomarker Data and Patient Preference Inform Perioperative Therapy Selection in Early HER2+ Breast Cancer - OncLive
~2y
Obesity May Contribute to Biological Differences in Breast Cancer Tumors - OncLive
~2y
Dr Ecker on the Investigation of the Microbiome in Pancreatic Cancer - OncLive
~2y
Dr Kalinsky on Remaining Treatment Questions in Breast Cancer - OncLive
~2y
Dr Jhaveri on Unanswered Questions in Breast Cancer Care - OncLive
~2y
Dr Ramnaraign on the Rationale for Examining irAEs in Older Patients With Kidney Cancer - OncLive
~2y
Reflecting on Advances Made in High-risk, Low-Grade Prostate Cancer Management - OncLive
~2y
Dr Murthy on the Use of CAR T-Cell Therapy in Elderly or Frail Patients With B-Cell Lymphomas - OncLive
~2y
Dr Stephen D. Nimer Named Researcher of the Year - OncLive
~2y
Responding to Resistance in Lung Cancer - OncLive
~2y
Trastuzumab Deruxtecan Shows Durable Responses in HER2-Mutated Solid Tumors - Targeted Oncology
~2y
Trastuzumab Deruxtecan Has Clinically Meaningful Activity in Solid Tumors Harboring HER2 Mutations - OncLive
~2y
Infection Risk Increases With Longer Surgical Duration in Lower Extremity Bone Tumors - OncLive
~2y
Dr Feun on the Evolving Treatment Paradigm in HCC - OncLive
~2y
Hurwitz on the Safety Profile of Simultaneous Integrated Boost Plus SBRT in Prostate Cancer - OncLive
~2y
Leveraging Endoscopic Ultrasound in Pancreatic Cancer: Looking to the Future - OncLive
~2y
Dr Aerts on the Rationale for the DENIM Trial in Mesothelioma - OncLive
~2y
Garcia-Manero and Zeidan Highlight Key Implications of the COMMANDS Trial in Lower-Risk MDS - OncLive
~2y
Deeper Understanding of immune System Could Advance Treatment Options in Lymphoma - OncLive
>2y
Dr. Schetelig on the Use of Induction Chemotherapy Prior to Allo-HCT in Relapsed/Refractory AML - OncLive
>2y
Dr Mehmi on the Rationale for Investigating Fianlimab/Cemiplimab in Advanced Melanoma - OncLive
>2y
Dr Miranda-Galvis on the Investigation of Social Determinants of Health in Hematologic Malignancies - OncLive
>2y
Dose Optimization Continues After Preliminary Efficacy, Safety Signals With BI 764532 in DLL3+ SCLC - OncLive
>2y
PRGN-2009 Plus Bintrafusp Alfa Shows Early Activity in HPV-Associated Malignancies - OncLive
>2y
Treating HER2+ Breast Cancer with CNS Involvement - OncLive
>2y